Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5221_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
21 Мб
Скачать
 Infectious Disease and Neurocognition
is milder than those related to other environmental or genetic factors, then memory of Toxoplasma- infected subjects could be better even if toxoplasmosis does have a detrimental impact on cognitive performance, including memory functions; for fur­ther explanation of this phenomenon, see the “birth weight paradox” in Pearl and Mackenzie (2018).
In the second decade of the twenty- rst century, there appeared several studies performed on general populations. Some of these, however, reported the results of independent analyses performed on the same population (based on the NHANES). For example, a cross- sectional study performed on 4485 senior members of NHANES III showed that Toxoplasma- infected subjects had worse immediate but intact delayed memory compared to Toxoplasma- free survey participants (Mendy et al., 2015). Similarly, a longitudinal 5- year study performed on a cohort of 1022 older participants of the Monongahela– Youghiogheny Healthy Aging Team study examined annually using a panel of cognitive tests, including the memory tests, showed that individuals infected with Toxoplasma but also herpesviruses (cyto- megalovirus, herpes simplex virus (HSV)- 2, but not HSV- 1) showed a signicantly greater cognitive decline over time than non- infected individuals did (Nimgaonkar et al., 2016).
A recent systematic meta- analytical study (De Haan et al., 2021) identied 13 in­dependent studies that reported a strong association between latent toxoplasmosis and various cognitive functions, including working memory and verbal memory in non- clinical populations. e authors found six studies reporting the eects of toxo­plasmosis on working memory with aggregate standardized mean dierence = 0.16, p = 0.002, and ve studies reporting short- term word memory with aggregate stand­ardized mean dierence = 0.18, p < 0.001.
Proximal causes of Toxoplasmosis- associated behavioral changes
e molecular and physiologic mechanisms underlying the behavioral changes re­main unknown. Several molecules, including dopamine, tryptophan and its metab­olites, and testosterone, have been named as possibly playing a role in inducing these changes.
Dopamine is not only a neurotransmitter but also an important cytokine pro­duced by some populations of leukocytes to enable an exchange of information between immunocytes in the course of immune processes. It is known that latent toxoplasmosis is associated with characteristic changes in the immune system in both rodents and humans (Flegr & Stříž, 2011; Kaňková et al., 2010). In the brain of infected mice, researchers found numerous perivascular and leptomeningeal inl­trations of inammatory cells (Figure 14.2) (Berenreiterová et al., 2011) located in dierent brain regions than the tissue cysts with bradyzoites (Berenreiterová et al., 2011; Hermes et al., 2008). Moreover, the local immune response needed to keep
Toxoplasmosis, Behavior, and Cognition 219
Figure 14.2 Perivascular infiltrations of inflammatory cells in the brain of a mouse infected with Toxoplasma gondii.
Source: Berenreiterová, M., Flegr, J., Kubena, A. A. & Nemec, P. 2011. The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: Implications for the behavioral manipulation hypothesis. PLoS One, 6, e28925.
Toxoplasma dormant may— through the production of proinammatory cytokines, interferon gamma, and indoleamine 2,3- dioxygenase— alter the levels, turnover, and eciency of many neuromodulators, including dopamine, glutamate, and ser­otonin (for details see, e.g., Skallová et al., 2005; Webster & McConkey, 2010). e dopamine hypothesis of Toxoplasma manipulation, proposed in 2003, was based on ndings regarding an increased concentration of dopamine in the brain of in­fected mice (Stibbs, 1985), on the well- known association between toxoplasmosis and schizophrenia (which is associated with and possibly caused by an increased concentration of dopamine in some regions of the brain of patients) (Carlsson, 1988; Creese et al., 1976), and on the results of human studies showing a decreased level of novelty seeking (a trait associated with high concentrations of dopamine in the brain tissue) (Flegr et al., 2003; Skallová et al., 2005). e hypothesis later received further support from the results of ethnopharmacological study performed on ro­dents (Skallová et al., 2006). e original dopamine hypothesis supposed that dopa­mine is produced by the host’s leukocytes, which are stimulated by the presence of Toxoplasma in the brain tissue. A later bioinformatic study, however, found that the genome of T. gondii contains two unique enzymes, which catalyze a limiting step of dopamine synthesis (Gaskell et al., 2009). An immunohistological study moreover demonstrated that the tissue cysts of Toxoplasma and their surrounding contain high concentrations of this neurotransmitter (Prandovszky et al., 2011).
 Infectious Disease and Neurocognition
Another molecule suspected of playing a role in the behavioral symptoms of la­tent toxoplasmosis is testosterone. It is known that male rats articially infected with Toxoplasma (Lim et al., 2013; Tan & Vyas, 2016; Vyas, 2015), as well as men with latent toxoplasmosis (Flegr et al., 2008a, 2008b), have increased levels of this sex hormone in the serum. Some indirect evidence of increased levels of testosterone in Toxoplasma- infected men has been reported in earlier studies. For example, in- fected male students were rated as more masculine and dominant (Hodkova et al.,
2007) and were, on average, 3 cm taller than their Toxoplasma- free peers (Flegr et al.,
2005). It has been suggested that Toxoplasma induces testosterone synthesis in the testes to inhibit the host’s immunity or to boost the sexual activity of infected males, which in turn increases the likelihood of sexual transmission between intermediate hosts (Flegr, 2015). On the other hand, the fact that Toxoplasma infection can induce the fatal attraction phenomenon (a loss of fear response to cat odor and its switch to attraction to that odor) in intact but not in castrated male rats (Lim et al., 2013) sug­gests that testosterone probably plays a far more specic role in the behavioral eects of toxoplasmosis.
e third class of molecules suspected of playing a proximal role in the induction of behavioral changes in Toxoplasma- infected hosts is tryptophan and its metabolites, specically kynurenic acids. It has been suggested that an increased concentration of this product of degradation of tryptophan could be responsible for an inhibition of glutamine and nicotine neurotransmitter receptors, both of which probably play an essential role in the symptoms of cognitive impairment associated with schizo­phrenia (Schwarcz & Hunter, 2007). A study performed on 950 non- clinical subjects showed that metabolites of tryptophan probably mediate the eect of toxoplasmosis on impulsivity in young men (Peng et al., 2018). While dopamine upregulation is usually considered a part of Toxoplasma’s manipulation activity (Barnard & Behnke,
1990), tryptophan degradation is part of a vertebrate host’s defense against various endoparasites, including Toxoplasma (MacKenzie et al., 2007).
It is, of course, possible that other molecules could also play a role in the behavioral eects of toxoplasmosis. For example, a recent study based on data from NHANES III showed that Toxoplasma could aect the concentration of folate and vitamin B12 in human brain and that these changes could be responsible for the decreased per­formance of infected individuals in specic performance tests (Berrett et al., 2017).
Manipulation or side eects of the disease?
For a long time, it had been thought that latent toxoplasmosis has no adverse eects on the health of infected subjects. In the past three decades, however, we have wit­nessed the publication of numerous anecdotal clinical observations that challenge this view (see the review part of Flegr et al., 2014). Within the past decade, several large cohort studies performed on the general population, as well as one ecological study, showed that latent toxoplasmosis does have a serious impact on physical and
Toxoplasmosis, Behavior, and Cognition 221
mental health. Toxoplasma- infected subjects suer from many diseases, including those with a severe impact on public health (such as hypertensive heart disease), as well as certain psychoses, signicantly more oen than Toxoplasma- free subjects. Toxoplasma- infected individuals also scored worse on 28 of 29 health- related vari­ables examined in the study (Flegr & Escudero, 2016; Flegr & Horáček, 2017, 2020; Šebánková & Flegr, 2017). e prevalence and incidence of many diseases and dis­orders and their impact on public health (measured as disability- adjusted life years) positively correlates with the prevalence of latent toxoplasmosis both worldwide and in European countries specically (Flegr et al., 2014). When per capita gross domestic product, latitude, and humidity were controlled for, dierences in the prevalence of toxoplasmosis explained approximately 23 percent of variability in the total disease burden in 27 European countries. ese new results suggest that Toxoplasma- infected subjects are chronically ill, either due to toxoplasmosis or due other disorders associated with a lifelong Toxoplasma infection. erefore, a pos- sible and parsimonious explanation of the observed behavioral changes is that they are the side eect of chronic or returning diseases rather than the eect of any ma­nipulative activity of Toxoplasma.
is side eect hypothesis was recently tested in a study performed on a cohort of 7762 members of the internet population using a 2- hour- long survey consisting of a panel of questionnaires and performance tests (Flegr et al., 2023). e results showed that subjects infected with Toxoplasma were in worse physical and mental health than the corresponding controls. e infected and non- infected subjects also diered in their behavioral and personality traits (conscientiousness, pathogen dis­gust, injury disgust, Machiavellianism, narcissism, tribalism, anti- authoritarianism, intelligence, reaction time, and precision). Structural equation modeling and non­parametric partial Kendall correlation tests controlled for physical or mental health showed that the observed behavioral eects were not mediated by impaired health of the infected individuals (Figure 14.3). In general, these results contradict the pre­dictions of the side eects hypothesis and support the hypothesis that behavioral changes are in fact a direct eect of toxoplasmosis. Of course, these ndings cannot falsify other (untested) hypotheses, for example, that the observed behavioral changes are the product of manipulation activity of Toxoplasma aimed primarily at an inhibition or modulation of activity of the immune system of Toxoplasma hosts.
Conclusion
Research on the behavioral eects of toxoplasmosis on rodents started approxi­mately 50 years ago and 30 years ago expanded to studies on infected humans. Since then, it has been found that latent Toxoplasma infection has a variety of both specic and nonspecic eects on the behavior of intermediate hosts and their performance in dierent cognitive performance tests. It is unclear whether the observed behav­ioral changes are the product of manipulation activity of the parasite, that is, whether
age
sex
0.14***
‒0.16***
conscientiousness
‒0.03
‒0.09**
‒0.09**
mental sickness
sex age
‒0.22***
0.07*
0.11***
0.08*
‒0.00
‒0.10***
‒0.08*
mental sickness
0.07*
sex age
‒0.07*‒0.08*
‒0.19***
0.03
‒0.02
‒0.06
mental sickness
age
sex
‒0.09**
0.15***
‒0.15***
0.12*** 0.12***
‒0.09**
toxoplasmosis
conscientiousness
‒0.10** ‒0.18***
0.06
‒0.10**
‒0.08*
0.06 0.05
toxoplasmosis
physical sickness
sex age
‒0.10***
‒0.22***
0.07*
0.11***
‒0.10***
toxoplasmosisintelligence intelligence
0.06
0.08*
‒0.07*
toxoplasmosis
‒0.08*
physical sickness
0.08*
sex age
‒0.08**
‒0.18***
0.12*** 0.12***
‒0.08**
pathogen disgust pathogen disgust
0.12**0.06 0.06
0.06
‒0.07*
‒0.08* ‒0.09**
toxoplasmosis toxoplasmosis
physical sickness
Figure 14.3 The results of path analyses showing that impaired health is not responsible for the eects of toxoplasmosis on human personality and cognitive
performance. Green arrows show positive, red arrows negative, and black arrows non- significant correlations. The numbers (standardized path coeicients)
and arrow widths indicate the strength of correlations. The number of asterisks (one, two, or three) indicates their significance (0.05, 0.01, and 0.001,
respectively).
Toxoplasmosis, Behavior, and Cognition 223
they are the result of an evolutionary adaptation of T. gondii. It is, however, clear that many of these changes are the product of Toxoplasma infection and that the in- tensity of some of these changes gradually increases with duration of the infection. Moreover, some behavioral changes might have a severe practical impact on human life and public health. For example, the increased risk of trac and workplace acci­dents might be responsible for hundreds of thousands of unnecessary deaths.
Similarly, the increased level of dopamine, which in most people probably leads only to a decrease in novelty seeking, could in predisposed people lead to the de­velopment of schizophrenia or obsessive– compulsive disorder. Possibly the most important result of the past 50 years of research on the behavioral eects of tox­oplasmosis is the realization that this widespread form of the disease is not clini­cally asymptomatic: it has a varied and strong impact on the physical and mental health of the general population. e main practical output of these studies is the recognition that an oral vaccine for feral, stray, and pet cats is urgently needed to either eradicate T. gondii or at least signicantly decrease its prevalence in popu- lated areas.
Acknowledgments
I want to thank Anna Pilátová for the nal revisions of our text and the Czech Science Foundation, grant number 22- 20785S for nancial support.
References
AKGUL, O. 2020. e eects of latent Toxoplasma gondii infection on the behavior and personality
characteristics of university students. Anadolu Psikiyatri Derg, 21, 70– 76.
ALVARADO- ESQUIVEL, C., ALANIS- QUINONES, O. P., ARREOLA- VALENZUELA, M. A.,
RODRIGUEZ- BRIONES, A., PIEDRA- NEVAREZ, L. J., DURAN- MORALES, E., ESTRADA­MARTINEZ, S., MARTINEZ- GARCIA, S. A. & LIESENFELD, O. 2006. Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infect Dis, 6, 178.
ALVARADO- ESQUIVEL, C., ESTRADA- MARTINEZ, S., RAMOS- NEVAREZ, A., PEREZ-
ALAMOS, A. R., BERISTAIN- GARCIA, I., ALVARADO- FELIX, A. O., CERRILLO- SOTO, S. M., ALVARADO- FELIX, G. A., GUIDO- ARREOLA, C. A., SAENZ- SOTO, L. & SIFUENTES­ALVAREZ, A. 2021. Is Toxoplasma gondii infection associated with sexual promiscuity? A cross­sectional study. Pathogens, 10, 8.
ALVARADO- ESQUIVEL, C., TORRES- CASTORENA, A., LIESENFELD, O., ESTRADA-
MARTINEZ, S. & URBINA- ALVAREZ, J. D. 2012. High seroprevalence of Toxoplasma gondii in­fection in a subset of Mexican patients with work accidents and low socioeconomic status. Parasit
Vectors, 5, 13. BARNARD, C. J. & BEHNKE, J. M. 1990. Parasitism and Host Behaviour. New York: Taylor and Francis. BAYANI, M., RIAHI, S. M., BAZRAFSHAN, N., GAMBLE, H. R. & ROSTAMI, A. 2019. Toxoplasma
gondii infection and risk of Parkinson and Alzheimer diseases: A systematic review and meta-
analysis on observational studies. Ac ta Tro p, 196, 165– 171. BERDOY, M., WEBSTER, J. P. & MACDONALD, D. W. 2000. Fatal attraction in rats infected with
Toxoplasma gondii. Proc R Soc B Biol Sci, 267, 1591– 1594.
 Infectious Disease and Neurocognition
BERENREITEROVÁ, M., FLEGR, J., KUBENA, A. A. & NEMEC, P. 2011. e distribution of
Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: Implications for the be­havioral manipulation hypothesis. PLoS One, 6, e28925.
BERRETT, A. N., GALE, S. D., ERICKSON, L. D., BROWN, B. L. & HEDGES, D. W. 2017. Toxoplasma
gondii moderates the association between multiple folate- cycle factors and cognitive function in US adults. Nutrients, 9, 564.
BHARTI, A. R., MCCUTCHAN, A., DEUTSCH, R., SMITH, D. M., ELLIS, R. J., CHERNER, M.,
WOODS, S. P., HEATON, R. K., GRANT, I. & LETENDRE, S. L. 2016. Latent Toxoplasma infection and higher Toxoplasma gondii immunoglobulin G levels are associated with worse neurocognitive functioning in HIV- infected adults. Clin Infect Dis, 63, 1655– 1660.
BORONOW, J., DICKERSON, F., STALLINGS, C., LEE, B., ORIGONI, A. & YOLKEN, R. 2002. HSV- 1,
CMV and Toxoplasma serology predict cognitive decits in schizophrenia. Schizophr Res, 53, 85– 85.
CARLSSON, A. 1988. e current status of the dopamine hypothesis of schizophrenia.
Neuropsychopharmacology, 1, 179– 186.
COCCARO, E. F., LEE, R., GROER, M. W., CAN, A., COUSSONS- READ, M. & POSTOLACHE, T.
T. 2016. Toxoplasma gondii infection: Relationship with aggression in psychiatric subjects. J Clin Psychiatry, 77, 334– 341.
COOK, T. B., BRENNER, L. A., CLONINGER, C. R., LANGENBERG, P., IGBIDE, A., GIEGLING, I.,
HARTMANN, A. M., KONTE, B., FRIEDL, M., BRUNDIN, L., GROER, M. W., CAN, A., RUJESCU, D. & POSTOLACHE, T. T. 2015. “Latent” infection with Toxoplasma gondii: Association with trait aggression and impulsivity in healthy adults. J Psychiatr Res, 60, 87– 94.
CREESE, I., BURT, D. R. & SNYDER, S. H. 1976. Dopamine receptor binding predicts clinical and
pharmacological potencies of antischizophrenic drugs. Science, 192, 481– 483.
DASS, S. A. H. & VYAS, A. 2014. Toxoplasma gondii infection reduces predator aversion in rats through
epigenetic modulation in the host medial amygdala. Mol Ecol, 23, 6114– 6122.
DE HAAN, L., SUTTERLAND, A. L., SCHOTBORGH, J. V., SCHIRMBECK, F. & DE HAAN, L. 2021.
Association of Toxoplasma gondii seropositivity with cognitive function in healthy people: A sys­tematic review and meta- analysis. JAMA Psychiatry, 78, 1103– 1112.
DICKERSON, F., STALLINGS, C., ORIGONI, A., KATSAFANAS, E., SCHWEINFURTH, L.,
SAVAGE, C., KHUSHALANI, S. & YOLKEN, R. 2014. Antibodies to Toxoplasma gondii and cog­nitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls. J Nerv Ment Dis, 202, 589– 593.
ENE, L., MARCOTTE, T. D., UMLAUF, A., GRANCEA, C., TEMEREANCA, A., BHARTI, A., ACHIM,
C. L., LETENDRE, S. & RUTA, S. M. 2016. Latent toxoplasmosis is associated with neurocognitive impairment in young adults with and without chronic HIV infection. J Neuroimmunol, 299, 1– 7.
FLEGR, J. 2013. Inuence of latent Toxoplasma infection on human personality, physiology and mor-
phology: Pros and cons of the Toxoplasma- human model in studying the manipulation hypothesis. J Exp Biol, 216, 127– 133.
FLEGR, J. 2015. Host manipulation by Toxoplasma gondii. In: MEHLHORN, H. (Ed.) Host
Manipulations by Parasites and Viruses. London: Springer, pp. 91– 99.
FLEGR, J. 2017a. Do Toxoplasma- infected subjects have better leadership skills? Comment on paper
“Puppet master: Possible inuence of the parasite Toxoplasma gondii on managers and employees.” Acad Manag Perspect, 31, 332– 338.
FLEGR, J. 2017b. Does Toxoplasma infection increase sexual masochism and submissiveness? Yes and
no. Commun Integr Biol, 10, 5– 6.
FLEGR, J. 2017c. Predictors of Toxoplasma gondii infection in Czech and Slovak populations: e pos-
sible role of cat- related injuries and risky sexual behavior in the parasite transmission. Epidemiol Infect, 145, 1351– 1362.
FLEGR, J. & DAMA, M. 2014. Does the prevalence of latent toxoplasmosis and frequency of Rhesus-
negative subjects correlate with the nationwide rate of trac accidents? Folia Parasitol, 61, 485– 494.
FLEGR, J. & ESCUDERO, D. Q. 2016. Impaired health status and increased incidence of diseases in
Toxoplasma- seropositive subjects— An explorative cross- sectional study. Parasitology, 143, 1974– 1989.
FLEGR, J. & HAVLÍČEK, J. 1999. Changes in the personality prole of young women with latent toxo-
plasmosis. Folia Parasitol, 46, 22– 28.
Toxoplasmosis, Behavior, and Cognition 225
FLEGR, J., HAVLÍČEK, J., KODYM, P., MALÝ, M. & ŠMAHEL, Z. 2002. Increased risk of trac acci-
dents in subjects with latent toxoplasmosis: A retrospective case- control study. BMC Infect Dis, 2, 11. FLEGR, J., HLAVACOVA, J. & TOMAN, J. 2023. Parasitic manipulation or side eects? e eects of
past Toxoplasma and Borrelia infections on human personality and cognitive performance are not
mediated by impaired health. MedRxiv. https:// doi.org/ 10.1101/ 2023.01.07.23284 298 FLEGR, J. & HORÁČEK, J. 2017. Toxoplasmosis, but not borreliosis, is associated with psychiatric dis-
orders: A cross- sectional survey on 46 thousand of subjects. BioRxiv. https:// doi.org/ 10.1101/ 231 803 FLEGR, J. & HORÁČEK, J. 2020. Negative eects of latent toxoplasmosis on mental health. Front
Psychiatry, 10, 1012. FLEGR, J. & HRDÝ, I. 1994. Inuence of chronic toxoplasmosis on some human personality factors.
Folia Parasitol, 41, 122– 126. FLEGR, J., HRUSKOVA, M., HODNY, Z., NOVOTNA, M. & HANUSOVA, J. 2005. Body height, body
mass index, waist- hip ratio, uctuating asymmetry and second to fourth digit ratio in subjects with
latent toxoplasmosis. Parasitology, 130, 621– 628. FLEGR, J., KLOSE, J., NOVOTNÁ, M., BERENREITTEROVÁ, M. & HAVLÍČEK, J. 2009. Increased
incidence of trac accidents in Toxoplasma- infected military drivers and protective eect RhD
molecule revealed by a large- scale prospective cohort study. BMC Infect Dis, 9, 72. FLEGR, J., KODYM, P. & TOLAROVÁ, V. 2000. Correlation of duration of latent Toxoplasma gondii
infection with personality changes in women. Biol Psychol, 53, 57– 68. FLEGR, J. & KUBA, R. 2016. e relation of Toxoplasma infection and sexual attraction to fear, danger,
pain, and submissiveness. Evol Psychol, 14, 1474704916659746. FLEGR, J., LENOCHOVÁ, P., HODNÝ, Z. & VONDROVÁ, M. 2011. Fatal attraction phenomenon in
humans– cat odour attractiveness increased for Toxoplasma- infected men while decreased for in-
fected women. PLoS Negl Trop Dis, 5, e1389. FLEGR, J., LINDOVÁ, J. & KODYM, P. 2008a. Sex- dependent toxoplasmosis- associated dierences in
testosterone concentration in humans. Parasitology, 135, 427– 431. FLEGR, J., LINDOVÁ, J., PIVOŇKOVÁ, V. & HAVLÍČEK, J. 2008b. Brief communication: Latent tox-
oplasmosis and salivary testosterone concentration- important confounding factors in second to
fourth digit ratio studies. Am J Phys Anthropol, 137, 479– 484. FLEGR, J. & MARKOS, A. 2014. Masterpiece of epigenetic engineering— How Toxoplasma gondii re-
programmes host brains to change fear to sexual attraction. Mol Ecol, 23, 5934– 5936. FLEGR, J., MILINSKI, M., KANKOVA, S., HULA, M., HLAVACOVA, J. & SYKOROVA, K. 2018a.
Latent toxoplasmosis and olfactory functions of Rh positive and Rh negative subjects. PLoS One, 13,
e0209773. FLEGR, J., NOVOTNÁ, M., LINDOVÁ, J. & HAVLÍČEK, J. 2008c. Neurophysiological eect of the
Rh factor. Protective role of the RhD molecule against Toxoplasma- induced impairment of reaction
times in women. Neuroendocrinol Lett, 29, 475– 481. FLEGR, J., PRANDOTA, J., SOVICKOVA, M. & ISRAILI, Z. H. 2014. Toxoplasmosis— A global threat.
Correlation of latent toxoplasmosis with specic disease burden in a set of 88 countries. PLoS One,
9, e90203. FLEGR, J., PREISS, M. & KLOSE, J. 2013. Toxoplasmosis- associated dierence in intelligence and
personality in men depends on their Rhesus blood group but not ABO blood group. PLoS One, 8,
e61272. FLEGR, J., PREISS, M., KLOSE, J., HAVLÍČEK, J., VITÁKOVÁ, M. & KODYM, P. 2003. Decreased level
of psychobiological factor novelty seeking and lower intelligence in men latently infected with the
protozoan parasite Toxoplasma gondii. Dopamine, a missing link between schizophrenia and toxo-
plasmosis? Biol Psychol, 63, 253– 268. FLEGR, J., ŠEBÁNKOVÁ, B., PŘÍPLATOVÁ, L., CHVÁTALOVÁ, V. & KAŇKOVÁ, Š. 2018b. Lower
performance of Toxoplasma- infected, Rh- negative subjects in the weight holding and hand- grip
tests. PLoS One, 13, e0200346. FLEGR, J. & STŘÍŽ, I. 2011. Potential immunomodulatory eects of latent toxoplasmosis in humans.
BMC Infect Dis, 11, 274. FLEGR, J., ZITKOVA, S., KODYM, P. & FRYNTA, D. 1996. Induction of changes in human behaviour
by the parasitic protozoan Toxoplasma gondii. Parasitology, 113, 49– 54.
 Infectious Disease and Neurocognition
GALE, S. D., BROWN, B. L., ERICKSON, L. D., BERRETT, A. & HEDGES, D. W. 2015. Association be-
tween latent toxoplasmosis and cognition in adults: A cross- sectional study. Parasitology, 142, 557– 565.
GALE, S. D., ERICKSON, L. D., BERRETT, A., BROWN, B. L. & HEDGES, D. W. 2016. Infectious disease
burden and cognitive function in young to middle- aged adults. Brain Behav Immun, 52, 161– 168.
GASKELL, E. A., SMITH, J. E., PINNEY, J. W., WESTHEAD, D. R. & MCCONKEY, G. A. 2009. A
unique dual activity amino acid hydroxylase in Toxoplasma gondii PLoS One, 4, e4801.
GOHARDEHI, S., SHARIF, M., SARVI, S., MOOSAZADEH, M., ALIZADEH- NAVAEI, R.,
HOSSEINI, S. A., AMOUEI, A., PAGHEH, A., SADEGHI, M. & DARYANI, A. 2018. e poten­tial risk of toxoplasmosis for trac accidents: A systematic review and meta- analysis. Exp Parasitol, 191, 19– 24.
HAMDANI, N., DABAN- HUARD, C., LAJNEF, M., GADEL, R., LE CORVOISIER, P., DELAVEST,
M., CARDE, S., LEPINE, J. P., JAMAIN, S., HOUENOU, J., GALEH, B., RICHARD, J. R., AOKI, M., CHARRON, D., KRISHNAMOORTHY, R., YOLKEN, R., DICKERSON, F., TAMOUZA, R. & LEBOYER, M. 2015. Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels. J Aect Disord, 179, 161– 166.
HAVLICEK, J., GASOVA, Z., SMITH, A. P., ZVARA, K. & FLEGR, J. 2001. Decrease of psychomotor
performance in subjects with latent “asymptomatic” toxoplasmosis. Parasitology, 122, 515– 520.
HERMES, G., AJIOKA, J. W., KELLY, K. A., MUI, E., ROBERTS, F., KASZA, K., MAYR, T., KIRISITS, M.
J., WOLLMANN, R., FERGUSON, D. J., ROBERTS, C. W., HWANG, J. H., TRENDLER, T., KENNAN, R. P., SUZUKI, Y., REARDON, C., HICKEY, W. F., CHEN, L. & MCLEOD, R. 2008. Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inammation, and neu­ronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinamm, 5, 48.
HLAVACOVA, J., FLEGR, J., REZABEK, K., CALDA, P. & KANKOVA, S. 2021. Male- to- female pre-
sumed transmission of Toxoplasmosis between sexual partners. Am J Epidemiol, 190, 386– 392.
HODKOVÁ, H., KOLBEKOVÁ, P., SKALLOVÁ, A., LINDOVÁ, J. & FLEGR, J. 2007. Higher perceived
dominance in Toxoplasma infected men— A new evidence for role of increased level of testosterone in toxoplasmosis- associated changes in human behavior. Neuroendocrinol Lett, 28, 110– 114.
HOLUB, D., MOTLOVÁ, L., DRAGOMIRECKÁ, E., NOVÁK, T., ČERMÁK, J., RODRIGUEZ, M.,
PREISS, M., UNGRMANOVÁ, M., PANOCHOVÁ, M. & FLEGR, J. 2008. Vigilance/ sustained at­tention abnormalities in subjects with latent toxoplasmosis. Psychiatrie, 12, 1– 5.
HUTCHISON, W. M., AITKEN, P. P. & WELLS, B. W. 1980a. Chronic Toxoplasma infections and
motor performance in the mouse. Ann Trop Med Parasitol, 74, 507– 510.
HUTCHISON, W. M., BRADLEY, M., CHEYNE, W. M., WELLS, B. W. P. & HAY, J. 1980b. Behavioural
abnormalities in Toxoplasma- infected mice. Ann Trop Med Parasitol, 74, 337– 345.
JOHNSON, S. K., FITZA, M. A., LERNER, D. A., CALHOUN, D. M., BELDON, M. A., CHAN, E. T. &
JOHNSON, P. T. J. 2018. Risky business: Linking Toxoplasma gondii infection and entrepreneurship behaviours across individuals and countries. Proc R Soc B Biol Sci, 285, 20180822.
KAŇKOVÁ, Š., HOLÁŇ, V., ZAJÍCOVÁ, A., KODYM, P. & FLEGR, J. 2010. Modulation of immu-
nity in mice with latent toxoplasmosis— e experimental support for the immunosuppression hy­pothesis of Toxoplasma- induced changes in reproduction of mice and humans. Parasitol Res, 107, 1421– 1427.
KODYM, P., MACHALA, L., ROHÁČOVÁ, H., ŠIROCKÁ, B. & MALÝ, M. 2007. Evaluation of a com-
mercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement xa­tion for the diagnosis of acute toxoplasmosis. Clin Microbiol Infect, 13, 40– 47.
KOLBEKOVÁ, P., KOURBATOVA, E., NOVOTNÁ, M., KODYM, P. & FLEGR, J. 2007. New and old
risk- factors for Toxoplasma gondii infection: Prospective cross- sectional study among military per­sonnel in the Czech Republic. Clin Microbiol Infect, 13, 1012– 1017.
KOPECKÝ, R., PŘÍPLATOVÁ, L., BOSCHETTI, S., TALMONT- KAMINSKI, K. & FLEGR, J. 2022.
Le Petit Machiavellian Prince: Eects of latent toxoplasmosis on political beliefs and values. Evol Psychol, 20, 13.
LANCHAVA, L., CARLSON, K., SEBANKOVA, B., FLEGR, J. & NAVE, G. 2015. No evidence of associa-
tion between Toxoplasma gondii infection and nancial risk taking in females. PLoS One, 10, e0136716.
LIM, A., KUMAR, V., DASS, S. A. H. & VYAS, A. 2013. Toxoplasma gondii infection enhances testic-
ular steroidogenesis in rats. Mol Ecol, 22, 102– 110.
Toxoplasmosis, Behavior, and Cognition 227
LINDOVÁ, J., KUBĚNA, A. A., ŠTURCOVÁ, A., KŘIVOHLAVÁ, R., NOVOTNÁ, M., RUBEŠOVÁ,
A., HAVLÍČEK, J., KODYM, P. & FLEGR, J. 2010. Pattern of money allocation in experimental
games supports the stress hypothesis of gender dierences in Toxoplasma gondii- induced behav-
ioural changes. Folia Parasitol, 57, 136– 142. LINDOVÁ, J., NOVOTNÁ, M., HAVLÍČEK, J., JOZÍFKOVÁ, E., SKALLOVÁ, A., KOLBEKOVÁ, P.,
HODNÝ, Z., KODYM, P. & FLEGR, J. 2006. Gender dierences in behavioural changes induced by
latent toxoplasmosis. Int J Parasitol, 36, 1485– 1492. LINDOVÁ, J., PRIPLATOVA, L. & FLEGR, J. 2012. Higher extraversion and lower conscientiousness
in humans infected with Toxoplasma. Eur J Pers, 26, 285– 291. LUFT, B. J. & REMINGTON, J. S. 1992. Toxoplasmic encephalitis in Aids. Clin Infect Dis, 15, 211– 222. MACKENZIE, C. R., HESELER, K., MULLER, A. & DAUBENER, W. 2007. Role of indoleamine 2,3-
dioxygenase in antimicrobial defence and immuno- regulation: Tryptophan depletion versus pro-
duction of toxic kynurenines. Curr Drug Metab, 8, 237– 244. MASSA, N. M., DUNCAN, E., JOVANOVIC, T., KERLEY, K., WENG, L., GENSLER, L., LEE, S. S.,
NORRHOLM, S., POWERS, A., ALMLI, L. M., GILLESPIE, C. F., RESSLER, K. & PEARCE, B. D.
2017. Relationship between Toxoplasma gondii seropositivity and acoustic startle response in an
inner- city population. Brain Behav Immun, 61, 176– 183. MENDY, A., VIEIRA, E. R., ALBATINEH, A. N. & GASANA, J. 2015. Immediate rather than delayed
memory impairment in older adults with latent toxoplasmosis. Brain Behav Immun, 45, 36– 40. MINTO, A. & ROBERTS, F. J. 1959. e psychiatric complications of toxoplasmosis. Lancet, 1, 1180– 1182. NIMGAONKAR, V. L., YOLKEN, R. H., WANG, T., CHANG, C. C., MCCLAIN, L., MCDADE, E.,
SNITZ, B. E. & GANGULI, M. 2016. Temporal cognitive decline associated with exposure to infec-
tious agents in a population- based, aging cohort. Alzheimer Dis Assoc Disord, 30, 216– 222. NOVOTNÁ, M., HAVLÍČEK, J., SMITH, A. P., KOLBEKOVÁ, P., SKALLOVÁ, A., KLOSE, J., GAŠOVÁ,
Z., PÍSAČKA, M., SECHOVSKÁ, M. & FLEGR, J. 2008. Toxoplasma and reaction time: Role of tox-
oplasmosis in the origin, preservation and geographical distribution of Rh blood group polymor-
phism. Parasitology, 135, 1253– 1261. OTIS, A. S. 1954. Otis Quick- Scoring Mental Ability Test (New ed.). Tarrytown- on- Hudson, NY: Word
Book Co. PAPPAS, G., ROUSSOS, N. & FALAGAS, M. E. 2009. Toxoplasmosis snapshots: Global status of
Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis.
Int J Parasitol, 39, 1385– 1394. PEARCE, B. D., HUBBARD, S., RIVERA, H. N., WILKINS, P. P., FISCH, M. C., HOPKINS, M. H.,
HASENKAMP, W., GROSS, R., BLIWISE, N., JONES, J. L. & DUNCAN, E. 2013. Toxoplasma gondii
exposure aects neural processing speed as measured by acoustic startle latency in schizophrenia
and controls. Schizophr Res, 150, 258– 261. PEARCE, B. D., KRUSZON- MORAN, D. & JONES, J. L. 2014. e association of Toxoplasma gondii
infection with neurocognitive decits in a population- based analysis. Soc Psychiatry Psychiatr
Epidemiol, 49, 1001– 1010. PEARL, J. & MACKENZIE, D. 2018. e Book of Why: e New Science of Cause and Eect. New York:
Basic Books. PENG, X. Q., BRENNER, L. A., MATHAI, A. J., COOK, T. B., FUCHS, D., POSTOLACHE, N., GROER,
M. W., PANDEY, J. P., MOHYUDDIN, F., GIEGLING, I., WADHAWAN, A., HARTMANN, A. M.,
KONTE, B., BRUNDIN, L., FRIEDL, M., STILLER, J. W., LOWRY, C. A., RUJESCU, D. & POSTOACHE,
T. T. 2018. Moderation of the relationship between Toxoplasma gondii seropositivity and trait impul-
sivity in younger men by the phenylalanine- tyrosine ratio. Psychiatry Res, 270, 992– 1000. POIROTTE, C., KAPPELER, P. M., NGOUBANGOYE, B., BOURGEOIS, S., MOUSSODJI, M. &
CHARPENTIER, M. J. E. 2016. Morbid attraction to leopard urine in Toxoplasma- infected chim-
panzees. Curr Biol, 26, R98– R99. PRANDOVSZKY, E., GASKELL, E., MARTIN, H., DUBEY, J. P., WEBSTER, J. P. & MCCONKEY, G. A.
2011. e neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One, 6, e23866.
PŘÍPLATOVÁ, L., ŠEBANKOVÁ, B. & FLEGR, J. 2014. Contrasting eect of prepulse signals on per-
formance of Toxoplasma- infected and Toxoplasma- free subjects in an acoustic reaction times test.
PLoS One, 9, e112771.